AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04727450 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Combination of cognitive and physical training (CCPT)-BIGMAP
Description: BIGMAP is a program engaging participants in specially designed cognitive/memory games together with physical training (Fu \& Chow, 2019).
Study NCT04736485 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: perioperative treatment
Description: FLOT + Spartalizumab
Study NCT05869331 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early mobilization
Description: Patients randomized to nonoperative treatment have already received treatment using early mobilization in the original trial, and all fractures have been confirmed healed. Mobilization consisted of 5 repetitions of full finger extension followed by maximum finger flexion, and 5 such sets of 5 were required per day for the first 6 weeks. Buddy taping or resting splint was offered if the patient experienced difficulty, and mobilization was performed by all patients in this treatment arm.
Study NCT06373354 — intervention group
Intervention type: DEVICE
Intervention: Digital Breast Tomosynthesis (DBT)
Description: Undergo tomosynthesis imaging
Study NCT05898581 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PENG Block
Description: Participants will receive a PENG block with local anesthetics (which is a freezing medication, in this case, 0.5% ropivacaine) before receiving spinal anesthesia.
Study NCT05898581 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Control Group
Description: Participants will receive a sham PENG block performed with 20ml of normal saline solution before spinal anesthesia. After, patients will receive ILAI (performed by the operating surgeon) with a plain solution of ropivacaine 0.25% 60ml.
Study NCT05869331 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Operative treatment
Description: Patients randomized to operative treatment have already received treatment using open reduction and internal fixation (ORIF) with cortical screws in the original trial, and all fractures have been confirmed healed. Surgery was performed under general anaesthesia through a dorsal incision centered over the fractured metacarpal. Reduction was performed under visual inspection and fixation performed using 2 or more cortical screws (Synthes Compact Hand 2.0) as first option. At the surgeons preference fixation using plate and screw fixation was also allowed. Postoperatively patients were put in a plaster cast for two weeks and then hand therapy was initiated.
Study NCT06288854 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: weight gain each group
Description: weight gain after 12 Weeks
Study NCT05540353 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transvaginal photobiomodulation
Description: Low light laser therapy applied transvaginally using a small vaginal wand with sterile disposable wand covers. The intervention last 3-5 minutes based on a surface area calculation performed at the beginning of the intervention, and involves a gentle in and out motion of the wand to deliver light energy to the muscles of the pelvic floor.
Study NCT05540353 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham therapy
Description: Use of the same vaginal wand as active arm, but without activation of the machine. The intervention last 3-5 minutes, and involves a gentle in and out motion of the wand to massage the muscles of the pelvic floor, without delivery of light therapy.
Study NCT06280768 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-2004 injection
Description: dose 1 or dose 2 or dose 3 or dose 4 or dose 5 or dose 6
Study NCT05339841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile health application
Description: The mHealth app delivers a personalized support program of digital health. Specifically, using ad hoc designed algorithms which uses the data self-reported by the subject and/or collected by the recruiter at baseline, the App delivers periodic messages with advice, motivational reminders and support to improve lifestyle habits and risk factor control.
Study NCT06331039 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PFMT
Description: PFM exercises were done. Each session were 45 minutes, 2 days a week on a group basis with the physiotherapist, and 1 day a week as a home program, for 12 weeks.
Study NCT06331039 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PFMT+Otago
Description: It were done by combining Otago exercises and PFM exercises. Each session were 45 minutes, 2 days a week on a group basis with the physiotherapist, and 1 day a week as a home program, for 12 weeks.
Study NCT06288854 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: weight gain each group
Description: weight gain after 12 Weeks
Study NCT05911360 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DTG/3TC
Description: DTG/3TC FDC will be administered once daily.
Study NCT05172271 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MagPro TMS Stimulator and coil
Description: TMS measurements of cortical excitability pre and post study intervention
Study NCT05172271 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thymatron(R) System IV
Description: The Thymatron(R) System IV (Somatics LLC, Venice, FL, USA) is an FDA 510(k)-cleared ECT device. For TESt, we will be using it in a non FDA-approved manner--stimulating without intending to induce seizures.
Study NCT05172271 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging Scanner
Description: Conventional MRI studies in this protocol are considered non-significant risk (NSR) devices. While operated in research mode, the MRI will be under the International Electrotechnical Commission (IEC) 60601-2-33 First Level Controlled Operating Mode, which allows for research pulse sequences to be used within the FDA/IEC safety limits for MRI devices.
Study NCT05172271 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: ECT device without stimulation
Description: Anesthesia alone
Study NCT05139589 — intervention group
Intervention type: OTHER
Intervention: None, observational
Description: Patients with infective endocarditis who do and do not undergo valve surgery compared with patientswithout endocarditis, who are operated on with similar valve surgery
Study NCT05412511 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MB-TB
Description: Training exercises with throwing a medicine ball will be performed for 30 seconds and the training volume will be consisted of 1 repetition.
Study NCT05412511 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MB-NTB
Description: Training exercises without throwing a medicine ball will be performed for 30 seconds and the training volume will be consisted of 1 repetition.
Study NCT03595150 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac
Description: Diclofenac rectally given before the ERCP to prevent pancreatitis
Study NCT06102512 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [¹⁴C]-LOXO-783
Description: Administered orally
Study NCT06102512 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LOXO-783
Description: Administered orally
Study NCT06102512 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [¹⁴C]-LOXO-783
Description: Administered IV
Study NCT05594485 — intervention group
Intervention type: DEVICE
Intervention: Carebot AI CXR
Description: Carebot AI CXR is a deep learning-based software that assists radiologists in the interpretation of chest radiographs in posterior-anterior (PA) or anterior-posterior (AP) projections. The solution with artificial intelligence automatically detects abnormality based on visual patterns for the following findings: atelectasis, consolidation, cardiomegaly, mediastinal widening, pneumoperitoneum, pneumothorax, pulmonary edema, pulmonary lesion, bone fracture, hilar enlargement, subcutaneous emphysema, and pleural effusion.
Study NCT05489198 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cataract surgery with Centurion phacoemulsification system
Description: Cataract surgery performed with the Centurion phacoemulsification system
Study NCT05489198 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cataract surgery with Quatera 700 phacoemulsification system
Description: Cataract surgery performed with the Quatera 700 phacoemulsification system
Study NCT06361030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: surufatinib combined with gemcitabine plus nab-paclitaxel
Description: Surufatinib capsules: oral, once daily. Combination treatment period: 200 mg each time, every 4 weeks for a treatment cycle(Q4W). If all the chemotherapy drugs were stopped during the maintenance treatment period, only surufatinib was left, the dose of Surufatinib could be increased to 300 mg per dose according to the patient\&#39;s condition.~Gemcitabine: iv, 1000 mg/m2, days 1, 8, and 15 of each treatment cycle, Q4W. Paclitaxel (albumin-bound), iv, 125mg/m2, on days 1, 8 and 15 of each treatment cycle, Q4W.~All they will be used until disease progression, death, intolerable toxicity, initiation of new antineoplastic therapy, withdrawal of consent, loss to follow-up, or any other protocol-specified event requiring treatment discontinuation or study closure, whichever occurred first.~But If surgical resection was performed, they will be only maintained for 6 months after surgery.
Study NCT05135091 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NRTX-1001
Description: Biological: NRTX-1001 is an experimental neural cell therapy product candidate derived from an allogeneic human embryonic stem cell line. The stem cells were converted into inhibitory nerve cells that produce GABA.
Study NCT05135091 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Comparator
Description: Sham Comparator.
Study NCT05176392 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Active rTMS
Description: Active rTMS will be given at the left dorsolateral prefrontal cortex with a double blind TMS coil.
Study NCT05176392 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active rTMS
Description: Active rTMS will be given at the left dorsolateral prefrontal cortex with a double blind TMS coil.
Study NCT05176392 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Headache Management Therapy
Description: Therapy will be provided on headache management.
Study NCT05176392 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Headache Management Therapy
Description: Therapy will be provided on headache management.
Study NCT05176392 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS
Description: Sham rTMS will be given at the left dorsolateral prefrontal cortex. All parameters of the treatment will appear identical to the active treatment, with only the rTMS coil used to administer the treatment flipped 180 degrees to prevent stimulation.
Study NCT05176392 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Sham rTMS
Description: Sham rTMS will be given at the left dorsolateral prefrontal cortex. All parameters of the treatment will appear identical to the active treatment, with only the rTMS coil used to administer the treatment flipped 180 degrees to prevent stimulation.
Study NCT05176392 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Headache Education Control
Description: In the control, educational sessions on headaches will be provided.
Study NCT05176392 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Headache Education Control
Description: In the control, educational sessions on headaches will be provided.
Study NCT04248322 — intervention group
Intervention type: BEHAVIORAL
Intervention: Semi-structured interview
Description: Using iterative, semi-structured interviews or focus groups to explore the lived experience with CC and usual customary care (UCC) of catheter users with NLUTD and their caretakers to generate user-defined themes regarding bladder function and catheter-related barriers and the daily impacts on one's life.
Study NCT06449677 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iLet Bionic Pancreas System (BP)
Description: The iLet Bionic Pancreas System (BP) consists of an integrated infusion pump, touchscreen display, Bluetooth radio, and insulin dosing algorithms, that automatically controls insulin delivery based on glucose values obtained by communicating with a CGM sensor.
Study NCT06449677 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: iLet Bionic Pancreas System (BP)
Description: The iLet Bionic Pancreas System (BP) consists of an integrated infusion pump, touchscreen display, Bluetooth radio, and insulin dosing algorithms, that automatically controls insulin delivery based on glucose values obtained by communicating with a CGM sensor.
Study NCT06449677 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care (UC)
Description: Usual Care consists in the participant existing insulin therapy (prior to enrollment) in conjunction with a study CGM. Existing insulin therapies are defined as multiple daily injections of insulin (MDI) or use of an insulin pump.
Study NCT06497374 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Efgartigimod Alfa Injection
Description: Efgartigimod+IVMP; IVMP; Efgartigimod
Study NCT06497374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efgartigimod Alfa Injection
Description: Efgartigimod+IVMP; IVMP; Efgartigimod
Study NCT06497374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High-dose intravenous methylprednisolone
Description: Efgartigimod+IVMP; IVMP; Efgartigimod
Study NCT04830215 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Brexpiprazole
Description: Oral brexpiprazole tablets as adjunctive therapy to ADT
Study NCT05442723 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: On-Pump CABG
Description: coronary artery grafting by using cardiopulmonary bypass machine
Study NCT05442723 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Off-Pump CABG
Description: coronary artery grafting by beating heart technique
Study NCT05091918 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: MotionSense
Description: MotionSense Wearable: Remote patient monitoring
Study NCT05562089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: A Paclitaxel Drug-Coated Balloon
Description: Size: 2.0mm-4.0mm x 15-30mm Coated drug: Prevail TM
Study NCT06242951 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: VO2 max assessment
Description: Measurement of the maximum oxygen consumption (VO2max) by a cardiopulmonary exercise test (CPET)
Study NCT06647511 — intervention group
Intervention type: DEVICE
Intervention: Nokia-Withings BPM Connect Blood Pressure Monitor
Description: At-home blood pressure (BP) measurements will be weekly via a blood pressure cuff (e.g., Nokia-Withings BPM (Beats per Minute) Connect), with measurements being manually entered into the study specific smartphone app.
Study NCT06647511 — intervention group
Intervention type: DEVICE
Intervention: Smartwatch Devices
Description: Passive continuous collection of digital data (e.g., daily heart rate trends, activity levels, sleep measurements) for exploratory outcomes will occur via Apple Watches and Fitbit Versa 3s, which are synced to a smartphone application.
Study NCT05349968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lipovirtide for injection
Description: Multiple dosing of Lipovirtide
Study NCT04051866 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment: Scaling and root planing (SRP)
Description: Removal of dental plaque and dental calculus from the surface of a tooth, from the surface of a tooth apical to the gingival margin accumulated in periodontal pockets, or from the surface coronal to the gingival margin.
Study NCT04051866 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Oral hygiene instructions
Description: Education for individual health regarding peridontal disease and its association with diabetes, as well as oral hygiene instructions that include the modified Bass technique, use of interproximal brushes and dental floss
Study NCT04051866 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oral hygiene instructions
Description: Education for individual health regarding peridontal disease and its association with diabetes, as well as oral hygiene instructions that include the modified Bass technique, use of interproximal brushes and dental floss
Study NCT04755920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SGM-101
Description: Fluorescence-guided surgery
Study NCT05778097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apalutamide 60mg Tab
Description: Apalutamide 60Mg Tab (4 x 60 mg) once daily on days 1-28 of a 28-day cycle
Study NCT05778097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy(ADT)
Description: The choice of ADT will be at discretion of the Investigator. Dosing (dose and frequency of administration) will be consistent with the prescribing information.
Study NCT06464692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABBV-400
Description: Intravenous (IV) Infusion
Study NCT04683315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFIRINOX Treatment Regimen
Description: This therapy will be 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX).
Study NCT04683315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine/Nab-paclitaxel Treatment Regimen
Description: This regimen will be nab-paclitaxel and gemcitabine.
Study NCT04683315 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Chemoradiation
Description: 50.4 Gy in 28 fractions.
Study NCT05599048 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperpolarized 13C-Pyruvate
Description: Given IV
Study NCT05599048 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Description: Imaging procedure
Study NCT05821569 — intervention group
Intervention type: OTHER
Intervention: Standard approach
Description: Adoption of standard approach (derived by Unicef guidelines) to breastfeed
Study NCT05821569 — intervention group
Intervention type: OTHER
Intervention: Biological nurturing
Description: Adoption of biological nurturing approach to breastfeed
Study NCT05171777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Atezolizumab will be administered on Day 1 of each 21-day cycle. Participants will receive atezolizumab according to their assigned route of administration (i.e., SC or IV) for the first three treatment cycles. At Cycle 4, participants will cross-over and receive atezolizumab administered according to the alternative route of administration for Cycles 4-6. This period of 3+3 cycles in both treatment arms constitutes the study Treatment Cross-over Period. After Cycle 6, participants will select how they would like atezolizumab to be administered (SC or IV) for the Treatment Continuation Period. The Treatment Continuation Period will continue until Cycle 16 for participants with early-stage NSCLC or until loss of clinical benefit, as determined by the investigator according to local standard of care, for patients with advanced NSCLC.
Study NCT04852055 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Advance Care Planning Video
Description: Clinical assistants determine who is the correct person to receive the informational materials. If the patient is the correct recipient, clinicians will send the informational materials to the patient at the assisted living center. If the proxy is the correct recipient, the clinical assistant will determine whether or not the proxy is using the existing online portal. If the proxy is using the portal, the informational materials will be sent electronically. If the proxy does not access the portal, the informational materials will be sent to their residences.
Study NCT05265104 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SDF with stainless steel crown
Description: Silver Diamine Fluoride (38%) applied to the carious lesion in the primary molars with a brush and the tooth is sealed with a stainless steel crown
Study NCT05265104 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diode laser application with stainless steel crown
Description: Diode laser will be applied to the carious lesions primary molars to eradicate the bacteria and then the tooth will be sealed with stainless steel crown
Study NCT05265104 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: stainless steel crown only
Description: the primary molars with carious lesions will be sealed with stainless steel crowns following the concept of hall technique
Study NCT05822960 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: far-infrared radiation
Description: far-infrared radiation on foot acupoints (Yinlingquan and Sanyinjiao acupoints) during dialysis
Study NCT04989660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 6% aqueous phenol
Description: 1.5 mL of 6% aqueous phenol will be injected at each target genicular nerve under ultrasound guidance.
Study NCT04989660 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic saline
Description: 1.5 mL of isotonic saline will be injected at each target genicular nerve under ultrasound guidance.
Study NCT05645276 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK129 IV infusion
Description: AK129 is administered intravenously according to the frequency and dosage of administration at different stages.